BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22794526)

  • 1. Quantification and characterization of micrometer and submicrometer subvisible particles in protein therapeutics by use of a suspended microchannel resonator.
    Patel AR; Lau D; Liu J
    Anal Chem; 2012 Aug; 84(15):6833-40. PubMed ID: 22794526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
    Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
    J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of syringe surfaces on protein formulations.
    Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
    J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range.
    Shah M; Rattray Z; Day K; Uddin S; Curtis R; van der Walle CF; Pluen A
    Int J Pharm; 2017 Mar; 519(1-2):58-66. PubMed ID: 28089934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.
    Helbig C; Ammann G; Menzen T; Friess W; Wuchner K; Hawe A
    J Pharm Sci; 2020 Jan; 109(1):264-276. PubMed ID: 30914272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.
    Corvari V; Narhi LO; Spitznagel TM; Afonina N; Cao S; Cash P; Cecchini I; DeFelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Weiskopf A; Wuchner K
    Biologicals; 2015 Nov; 43(6):457-73. PubMed ID: 26324466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.
    Bai S; Landsman P; Spencer A; DeCollibus D; Vega F; Temel DB; Houde D; Henderson O; Brader ML
    J Pharm Sci; 2016 Jan; 105(1):50-63. PubMed ID: 26852839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes.
    Gerhardt A; Nguyen BH; Lewus R; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 May; 104(5):1601-9. PubMed ID: 25740412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals.
    Krause N; Kuhn S; Frotscher E; Nikels F; Hawe A; Garidel P; Menzen T
    AAPS J; 2021 Jan; 23(1):13. PubMed ID: 33398482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations.
    Ludwig DB; Trotter JT; Gabrielson JP; Carpenter JF; Randolph TW
    Anal Biochem; 2011 Mar; 410(2):191-9. PubMed ID: 21146492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silicone-oil-based subvisible particles: their detection, interactions, and regulation in prefilled container closure systems for biopharmaceuticals.
    Felsovalyi F; Janvier S; Jouffray S; Soukiassian H; Mangiagalli P
    J Pharm Sci; 2012 Dec; 101(12):4569-83. PubMed ID: 23023774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albinterferon α2b adsorption to silicone oil-water interfaces: effects on protein conformation, aggregation, and subvisible particle formation.
    Basu P; Blake-Haskins AW; O'Berry KB; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Feb; 103(2):427-36. PubMed ID: 24382812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle Characterization for a Protein Drug Product Stored in Pre-Filled Syringes Using Micro-Flow Imaging, Archimedes, and Quartz Crystal Microbalance with Dissipation.
    Zheng S; Puri A; Li J; Jaiswal A; Adams M
    AAPS J; 2017 Jan; 19(1):110-116. PubMed ID: 27620008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods.
    Werk T; Volkin DB; Mahler HC
    Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
    Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
    J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of subvisible silicone oil droplets from irregular standard dust particles.
    Vandesteeg N; Kilbert C
    J Pharm Sci; 2013 Jun; 102(6):1696-1700. PubMed ID: 23595940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colloidal Instability Fosters Agglomeration of Subvisible Particles Created by Rupture of Gels of a Monoclonal Antibody Formed at Silicone Oil-Water Interfaces.
    Mehta SB; Carpenter JF; Randolph TW
    J Pharm Sci; 2016 Aug; 105(8):2338-48. PubMed ID: 27422087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-flow imaging and resonant mass measurement (Archimedes)--complementary methods to quantitatively differentiate protein particles and silicone oil droplets.
    Weinbuch D; Zölls S; Wiggenhorn M; Friess W; Winter G; Jiskoot W; Hawe A
    J Pharm Sci; 2013 Jul; 102(7):2152-65. PubMed ID: 23625851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introducing the Alba
    Chillon A; Pace A; Zuccato D
    PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers.
    Basu P; Krishnan S; Thirumangalathu R; Randolph TW; Carpenter JF
    J Pharm Sci; 2013 Mar; 102(3):852-65. PubMed ID: 23280943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.